Trxade Health Profit Margin

As of the most recent data (June 2026), MEDS shows a profit margin of -9173.52%. That compares with 7453.12% in the prior-year period — down 223.1% year over year. That is below the Finance sector average of 17.27%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MEDS's profit margin is now -9173.52% (was 7453.12%) — a 223.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Trxade Health is outperforming or lagging.

The Finance sector average profit margin is about 17.27%. Trxade Health is at -9173.52%, which is lower that average. That is roughly 53231.7% below the sector mean. Use the comparison chart on this page to see how MEDS stacks up against individual peers as well.

That compares with 7453.12% in the prior-year period — down 223.1% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Trxade Health with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Trxade Health's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -9173.52%) with ownership activity and broader fundamentals.